News
1d
Adweek on MSNEli Lilly's Big Task: Become a Loved and Trusted Pharma BrandA new film from Eli Lilly sounds like a recruitment ad, but it doubles as a brand manifesto to showcase the pharmaceutical ...
Now, this won't come as too much of a surprise to Eli Lilly and its peers. A few weeks ago, the company's CEO, David Ricks, ...
Unlike the Get Better campaign — which was built throughout last year — Seeking launched with a full body of creative work, ...
Merck Animal Health will invest $895 million to expand vaccine manufacturing and R&D in Kansas, while Lilly is committing ...
5d
Pharmaceutical Technology on MSNLilly-Purdue partnership to invest $250m in pharma innovationEli Lilly and Purdue University, US, have announced the widening of their existing partnership with a planned investment of ...
The Lilly announcement will extend an agreement aimed at accelerating medicine development and bolstering the ...
Eli Lilly and many other drugmakers do quite a bit of manufacturing abroad since it's cheaper. The tariffs could increase manufacturing costs and lead to lower margins and profits for the leading ...
Eli Lilly and Purdue University expand their partnership with a $250 million investment to advance pharmaceutical innovation ...
Gov. Mike Braun visited Lebanon Tuesday to help break ground for the $4.5 billion Eli Lilly Medicine Foundry in Lebanon. The foundry is the first research and development site of its kind in the world ...
For the 2025 outlook, Novo Nordisk now expects 13-21% revenue increase at constant exchange rates (CER). Operating profit is expected at 16-24% growth. However, this forecast, 3% lower for revenue and ...
The pharmaceutical industry's patience is wearing thin with the Trump administration's pressure. But the administration doesn ...
Eli Lilly recently announced the impressive results of its SURMOUNT-5 trial, highlighting Zepbound's efficacy over Wegovy in weight management. This promising development was disclosed alongside ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results